• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

(D341-0349)

1

Identification

D341-0349 D341-0349
Name D341-0349
Formula C21H17N3S
MW 343.44
CAS No.
EINECS
Smiles C12SC=C(C3C=CC=CC=3)C1=C(N1CC3C=CC=CC=3CC1)N=CN=2
Synonyms
InChI InChI=1S/C21H17N3S/c1-2-7-16(8-3-1)18-13-25-21-19(18)20(22-14-23-21)24-11-10-15-6-4-5-9-17(15)12-24/h1-9,13-14H,10-12H2
2

Introduction

D341-0349 is a novel cyclin-dependent kinase 8 (CDK8) inhibitor. The inhibition rate is 50.8±2.6% at 10 μM. CDK8 gene expression correlates with increased mortality in colorectal, breast, and ovarian cancers and its overexpression is essential for the proliferation of cancer cells. Due to its key roles in oncogenesis, CDK8 has recently attracted considerable attention. Inhibitors of CDK8 offer a novel strategy for the treatment of various cancers.

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB100692271

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways Cell Cycle/DNA Damage
Target CDK
Research Area Neurological Disease
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of D341-0349

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
AMEDCHEM CHINA
10

Related Products

Other Forms of

Name CAS No Formula MW

Recommended Compounds in CDK

Name CAS No Formula MW
LY2857785 1619903-54-6 C26H36N6O 448.6
THZ2 1604810-84-5 C31H28ClN7O2 566.0527
Palbociclib (isethionate) 827022-33-3 C26H35N7O6S 573.66
CDK9-IN-6 1391855-95-0 C27H37ClN6O2 513.07468
ML167 1285702-20-6 C19H17N3O3 335.36
AMG 925 1401033-86-0 C26H29N7O2 471.55
LDC000067 1073485-20-7 C18H18N4O3S 370.43
LEE011 (succinate hydrate) 1374639-79-8 C27H38N8O6X 570.64
LEE011 (succinate) 1374639-75-4 C27H36N8O5 552.63
LEE011 (hydrochloride) 1211443-80-9 C23H31ClN8O 471.0
LEE011 1211441-98-3 C23H30N8O 434.54
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 333.77
Wogonin 632-85-9 C16H12O5 284.26
1-NM-PP1 221244-14-0 C20H21N5 331.41
WHI-P180 211555-08-7 C16H15N3O3 297.31
THZ1 1604810-83-4 C31H28ClN7O2 566.05
Senexin A 1366002-50-7 C17H14N4 274.32
CDK4-IN-1 1256963-02-6 C22H29ClN8 440.97
Palbociclib (hydrochloride) 827022-32-2 C24H30ClN7O2 483.99
Purvalanol B 212844-54-7 C20H25ClN6O3 432.9

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

D341-0349

Tags: buy D341-0349 IC50 | D341-0349 price | D341-0349 cost | D341-0349 solubility | D341-0349 purchase | D341-0349 manufacturer | D341-0349 research buy | D341-0349 order | D341-0349 MSDS | D341-0349 chemical structure | D341-0349 Storage condition | D341-0349 molecular weight | D341-0349 mw | D341-0349 datasheet | D341-0349 supplier | D341-0349 cell line | D341-0349 NMR | D341-0349 MS | D341-0349 IR | D341-0349 solubility | D341-0349 Safe information | D341-0349 Qc and Spectral Information | D341-0349 Clinical Information | D341-0349 Clinical Trial | D341-0349 Route of Synthesis | D341-0349 storage condition | D341-0349 diseases and conditions | D341-0349 flash point | D341-0349 boiling point | D341-0349 melting point | D341-0349 storage condition | D341-0349 brand